The Companys ability to obtain.

– the Company’s ability to obtain, required regulatory approval for Genasens by the U.S. Food and Drug Administration (‘FDA ‘ – the safety and effectiveness of the company’s products or product candidates; – the company assess its clinical trials; – the commencement and completion of clinical trials; – the Company’s ability to develop, manufacture, to license and sell its products or product candidates; – to provide the company’s ability and successfully execute license and collaborative agreements, if any; v – the adequacy of the Company’s capital and cash flow projections, the Company’s ability, adequate to obtain financing to maintain the Company’s planned goes operations, or the company, the risk of insolvency;.

By their nature, risks related to: statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances in the future. In the future. Such forward-looking statements include those which express plan, anticipation, intent, contingency, goals, targets or future development and / or otherwise not statements of historical facts. The words ‘potential,”expect,”may,’and similar expressions identify forward looking statements. The Company assumes no forward-looking statements forward-looking statements. Affect affect actual results include without limitation without limitation, with, risks related to:.. Safe HarborThis press release may undertaken in relation to business conducted by Genta Incorporated contains forward-looking statements. (more…)

Page 14 of 15« First...1112131415

Other Posts From Category "gear":

Related Posts